A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

Completed · Phase 2 · Has a placebo group

Conditions studied: Atherosclerosis

In brief

The purpose of this study is to evaluate the safety and efficacy of K-604 for the treatment of atherosclerosis.

Key facts

Study ID

NCT00851500

Run by

Kowa Research Institute, Inc.

People needed

210

Starts

2009-02-01

Expected to finish

2011-08-01

Last updated by the study team

2011-08-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• moderate carotid artery stenosis

You may not qualify if…

• history of arteritis
• heavily calcified plaque
• uncontrolled hypertension
• poorly controlled diabetes
• hypercholesterolemia

Where it is running

• Study site — Chandler, Arizona, United States
• Study site — Litchfield Park, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Los Angeles, California, United States
• Study site — San Diego, California, United States
• Study site — Clearwater, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — St Louis, Missouri, United States
• Study site — Buffalo, New York, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Carrollton, Texas, United States
• Study site — Dallas, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Plano, Texas, United States
• Study site — Norfolk, Virginia, United States
• Study site — Virginia Beach, Virginia, United States
• Study site — Olympia, Washington, United States
• Study site — Renton, Washington, United States
• Study site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.